Michael R Nadorff1,2, Danielle K Nadorff1, Anne Germain3. 1. Department of Psychology, Mississippi State University, Mississippi State, MS. 2. Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, TX. 3. Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA.
Abstract
OBJECTIVE: Nightmares are a robust and modifiable predictor of increased suicidality and poor psychiatric outcomes, yet nightmare screening and treatment remain rare, even in sleep centers. This paper aims to examine what proportion of nightmare sufferers have discussed nightmares with a healthcare provider, as well as possible explanations for low rates of nightmare complaints. METHODS: The present study utilized a large United States community sample recruited through mTurk and a student sample recruited from a large public university in the Southeast United States. In Study 1, participants (n = 809) were asked whether they had discussed nightmares with a healthcare provider. In Study 2 participants (n = 747) were asked whether they believed nightmares were treatable in addition to whether or not they had discussed nightmares with a healthcare provider. RESULTS: Of the participants in Study 1 experiencing clinically significant nightmare symptoms only 37.8% of participants reported discussing their nightmares with a healthcare professional. In Study 2 only 11.1% of participants with significant nightmares reporting having told a healthcare provider about their nightmares. Further, of these individuals with clinically significant nightmare symptoms, less than one-third believed that nightmares were treatable. Higher nightmare severity was associated with a greater likelihood of reporting nightmares to a healthcare physician as well as with lower beliefs that nightmares are treatable. CONCLUSIONS: Our findings suggest that nightmares are rarely reported to healthcare providers, which may explain the underutilization of nightmare treatments. Given the poor outcomes associated with nightmares, nightmare screening is warranted.
OBJECTIVE: Nightmares are a robust and modifiable predictor of increased suicidality and poor psychiatric outcomes, yet nightmare screening and treatment remain rare, even in sleep centers. This paper aims to examine what proportion of nightmare sufferers have discussed nightmares with a healthcare provider, as well as possible explanations for low rates of nightmare complaints. METHODS: The present study utilized a large United States community sample recruited through mTurk and a student sample recruited from a large public university in the Southeast United States. In Study 1, participants (n = 809) were asked whether they had discussed nightmares with a healthcare provider. In Study 2 participants (n = 747) were asked whether they believed nightmares were treatable in addition to whether or not they had discussed nightmares with a healthcare provider. RESULTS: Of the participants in Study 1 experiencing clinically significant nightmare symptoms only 37.8% of participants reported discussing their nightmares with a healthcare professional. In Study 2 only 11.1% of participants with significant nightmares reporting having told a healthcare provider about their nightmares. Further, of these individuals with clinically significant nightmare symptoms, less than one-third believed that nightmares were treatable. Higher nightmare severity was associated with a greater likelihood of reporting nightmares to a healthcare physician as well as with lower beliefs that nightmares are treatable. CONCLUSIONS: Our findings suggest that nightmares are rarely reported to healthcare providers, which may explain the underutilization of nightmare treatments. Given the poor outcomes associated with nightmares, nightmare screening is warranted.
Authors: B Krakow; M Hollifield; R Schrader; M Koss; D Tandberg; J Lauriello; L McBride; T D Warner; D Cheng; T Edmond; R Kellner Journal: J Trauma Stress Date: 2000-10
Authors: Michael R Nadorff; Ben Porter; Howard M Rhoades; Anthony J Greisinger; Mark E Kunik; Melinda A Stanley Journal: Behav Sleep Med Date: 2013-03-07 Impact factor: 2.964
Authors: Michael R Nadorff; Michael D Anestis; Sarra Nazem; H Claire Harris; E Samuel Winer Journal: J Affect Disord Date: 2013-10-17 Impact factor: 4.839
Authors: Barry J Krakow; Dominic C Melendrez; Lisa G Johnston; James O Clark; Erin M Santana; Teddy D Warner; Michael A Hollifield; Ron Schrader; Brandy N Sisley; Samuel A Lee Journal: J Clin Psychiatry Date: 2002-08 Impact factor: 4.384
Authors: Kristi E Pruiksma; Danica C Slavish; Daniel J Taylor; Jessica R Dietch; Hannah Tyler; Megan Dolan; AnnaBelle O Bryan; Craig J Bryan Journal: Int J Behav Med Date: 2021-04
Authors: Jennifer L Creamer; Matthew S Brock; Panagiotis Matsangas; Vida Motamedi; Vincent Mysliwiec Journal: J Clin Sleep Med Date: 2018-03-15 Impact factor: 4.062
Authors: Michael Schredl; Maria Gilles; Isabell Wolf; Verena Peus; Barbara Scharnholz; Marc Sütterlin; Svenja Bardtke; Tabea Sarah Send; Angelina Samaras; Michael Deuschle Journal: J Clin Sleep Med Date: 2019-09-15 Impact factor: 4.062